Early prediction of preeclampsia using a blood-derived biomarker
A liquid-biopsy approach that measures DNA-methylation levels in the blood may improve the detection of pregnancies at risk of developing preeclampsia at early stages, a study published in Nature Medicine shows. Preeclampsia is a major cause of morbidities during gestation. Early-onset preeclampsia — occurring before 34 weeks of gestation — is associated with a higher risk of…
Read More “Early prediction of preeclampsia using a blood-derived biomarker” »